HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management of evaporative dry eye in ectrodactyly-ectodermal dysplasia-clefting syndrome.

AbstractPURPOSE:
The purpose of this study is to report the features of dry eye and ocular surface disease in an unusual case of ectrodactyly-ectodermal dysplasia-clefting (EEC) syndrome.
CASE REPORT:
A single observational case report of a 22-year-old Japanese male with evaporative dry eye and corneal epithelial disease because of lipid layer abnormality resulting from meibomian gland agenesis was treated successfully with low dose lipid base ointment application.
DISCUSSION:
The clinical features of the dry eye and ocular surface disease and management issues are discussed.
CONCLUSION:
Low dose lipid base ointment application may be a promising treatment modality for the ocular surface disease in ectrodactyly-ectodermal dysplasia (EEC)-clefting syndrome, which seems to help in alleviating the subjective complaints and in improving the objective clinical findings.
AuthorsYu Ota, Yukihiro Matsumoto, Murat Dogru, Eiki Goto, Yuichi Uchino, Koji Endo, Kazuo Tsubota
JournalOptometry and vision science : official publication of the American Academy of Optometry (Optom Vis Sci) Vol. 85 Issue 9 Pg. E795-801 (Sep 2008) ISSN: 1538-9235 [Electronic] United States
PMID18772710 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Lipids
  • Ointments
  • Ophthalmic Solutions
  • Ofloxacin
Topics
  • Adult
  • Corneal Diseases (drug therapy, etiology, metabolism)
  • Dry Eye Syndromes (drug therapy, etiology, metabolism)
  • Ectodermal Dysplasia (complications, genetics)
  • Eye Abnormalities (complications, genetics)
  • Foot Deformities, Congenital (complications, genetics)
  • Hand Deformities, Congenital (complications, genetics)
  • Humans
  • Lipids (deficiency)
  • Male
  • Meibomian Glands (abnormalities)
  • Ofloxacin (administration & dosage)
  • Ointments
  • Ophthalmic Solutions (administration & dosage)
  • Syndrome
  • Tears (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: